毒性甲状腺腺瘤

Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.

• 全文
• 摘要

Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.

• 全文
• 摘要

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.

• 全文
• 摘要

1.  Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.

• 全文
• 摘要

2.  Hamburger JI, Taylor CI. Transient thyrotoxicosis associated with acute hemorrhagic infarction of autonomously functioning thyroid nodules. Ann Intern Med. 1979 Sep;91(3):406-9.

• 摘要

3.  Muller AF, Berghout A, Wiersing WM, et al. Thyroid function disorders - guidelines of the Netherlands Association of Internal Medicine. Neth J Med. 2008 Mar;66(3):134-42.

• 全文
• 摘要

4.  Abraham-Nordling M, Törring O, Lantz M, et al. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. Eur J Endocrinol. 2008;158(6):823-7.

• 全文
• 摘要

5.  Cooper DS. Hyperthyroidism. Lancet. 2003 Aug 9;362(9382):459-68.

• 摘要

6.  Corvilain B. The natural history of thyroid autonomy and hot nodules. Ann Endocrinol (Paris). 2003 Feb;64(1):17-22.

• 摘要

7.  Tonacchera M, Vitti P, De Servi M, et al. Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis. J Endocrinol Invest. 2003;26(2 suppl):2-6.

• 摘要

8.  Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.

• 全文
• 摘要

9.  Brtko J, Bobalova J, Podoba J, et al. Thyroid hormone receptors and type I iodothyronine 5'-deiodinase activity of human thyroid toxic adenomas and benign cold nodules. Exp Clin Endocrinol Diabetes. 2002 Jun;110(4):166-70.

• 摘要

10.  Krohn K, Führer D, Holzapfel HP, et al. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab. 1998 Jan;83(1):130-4.

• 摘要

11.  Tonacchera M, Vitti P, Agretti P, et al. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms. J Clin Endocrinol Metab. 1999 Nov;84(11):4155-8.

• 摘要

12.  Parma J, Duprez L, Van Sande J, et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab. 1997 Aug;82(8):2695-701.

• 摘要

13.  Georgopoulos NA, Sykiotis GP, Sgourou A, et al. Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol. 2003 Oct;149(4):287-92.

• 摘要

14.  Trulzsch B, Krohn K, Wonerow P, et al. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med. 2001;78(12):684-91.

• 摘要

15.  Derwahl M. TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas - a note of caution. J Clin Endocrinol Metab. 1996 Aug;81(8):2783-5.

• 摘要

16.  Krohn K, Fuhrer D, Bayer Y, et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev. 2005 Jun;26(4):504-24.

• 摘要

17.  Bartalena L, Bogazzi F, Chiovato L, et al. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018 Mar;7(2):55-66.

• 全文
• 摘要

18.  Morris AJ, Malbon CC. Physiological regulation of G protein-linked signaling. Physiol Rev. 1999 Oct;79(4):1373-430.

• 摘要

19.  Poertl S, Kirner J, Saller B, et al. T3-release from autonomously functioning thyroid nodules in vitro. Exp Clin Endocrinol Diabetes. 1998;106(6):489-93.

• 摘要

20.  Polak M. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene. Arch Med Res. 1999 Nov-Dec;30(6):510-3.

• 摘要

21.  Derwahl M, Hamacher C, Russo D, et al. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab. 1996 May;81(5):1898-904.

• 摘要

22.  Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.

• 全文
• 摘要

23.  Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.

• 全文
• 摘要

24.  Kakuno Y, Amino N, Kanoh M, et al. Menstrual disturbances in various thyroid diseases. Endocr J. 2010;57(12):1017-22.

• 全文
• 摘要

25.  Gorenek B, Boriani G, Dan GA, et al. European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). Europace. 2018 Jun 1;20(6):895-6.

• 全文
• 摘要

26.  Intenzo CM, dePapp AE, Jabbour S, et al. Scintigraphic manifestations of thyrotoxicosis. Radiographics. 2003 Jul-Aug;23(4):857-69.

• 摘要

27.  Baldini M, Orsatti A, Cantalamessa L. A singular case of Graves' disease in congenital thyroid hemiagenesis. Horm Res. 2005;63(3):107-10.

• 摘要

28.  US Preventive Services Task Force. Thyroid dysfunction: screening. July 2015 [internet publication].

• 全文

29.  Tankeu AT, Azabji-Kenfack M, Nganou CN, et al. Effect of propranolol on heart rate variability in hyperthyroidism. BMC Res Notes. 2018 Feb 22;11(1):151.

• 全文
• 摘要

30.  Ross DS. Radioiodine therapy for hyperthyroidism. N Engl J Med. 2011 Feb 10;364(6):542-50.

• 摘要

31.  Tarantini B, Ciuoli C, DiCairano G, et al. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. J Endocrinol Invest. 2006 Jul-Aug;29(7):594-8.

• 摘要

32.  Nygaard B, Hegedus L, Nielsen KG, et al. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf). 1999 Feb;50(2):197-202.

• 摘要

33.  Erdogan MF, Kucuk NO, Anil C, et al. Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas. Nucl Med Commun. 2004 Nov;25(11):1083-7.

• 摘要

34.  De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Aug;97(8):2543-65.

• 全文
• 摘要

35.  Andersen SL, Olsen J, Wu CS, et al. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 2013 Nov;98(11):4373-81.

• 全文
• 摘要

36.  Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017 Mar;27(3):315-89.

• 全文
• 摘要

37.  Vadiveloo T, Donnan PT, Cochrane L, et al. The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011 May;96(5):1344-51.

• 摘要

38.  Lee JS, Buzková P, Fink HA, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010 Nov 22;170(21):1876-83.

• 全文
• 摘要

39.  Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14;291(2):228-38.

• 摘要

40.  Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005 Jan;90(1):581-5; discussion 586-7.

• 摘要

41.  Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012 Mar 24;379(9821):1142-54.

• 摘要

42.  Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008 Feb;29(1):76-131.

• 摘要

43.  Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ. 2006 Jun 10;332(7554):1369-73.

• 摘要

44.  Reid JR, Wheeler SF. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2005 Aug 15;72(4):623-30.

• 摘要

45.  Cooper DS. Antithyroid drugs. N Engl J Med. 2005 Mar 3;352(9):905-17.

• 摘要

46.  Karras S, Tzotzas T, Krassas GE. Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives. Hormones (Athens). 2009 Oct-Dec;8(4):254-7.

• 摘要

47.  Barile A, Quarchioni S, Bruno F, et al. Interventional radiology of the thyroid gland: critical review and state of the art. Gland Surg. 2018 Apr;7(2):132-46.

• 全文
• 摘要

48.  Gharib H, Hegedüs L, Pacella CM, et al. Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013 Oct;98(10):3949-57.

• 全文
• 摘要

49.  Døssing H, Bennedbaek FN, Bonnema SJ, et al. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007 Jul;157(1):95-100.

• 摘要

50.  Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015 May;100(5):1903-11.

• 摘要

51.  Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004 Oct 21;351(17):1764-71.

• 摘要

52.  Ceccarelli C, Bencivelli W, Vitti P, et al. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. Clin Endocrinol (Oxf). 2005 Mar;62(3):331-5.

• 摘要

53.  Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med. 2001 Aug 16;345(7):512-6.

• 摘要

54.  Gorka J, Taylor-Gjevre RM, Arnason T. Metabolic and clinical consequences of hyperthyroidism on bone density. Int J Endocrinol. 2013;2013:638727.

• 全文
• 摘要

55.  Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet. 2012 Mar 24;379(9821):1155-66.

• 摘要

56.  Tzavara I, Tzanela M, Vlassopoulou B, et al. Long term thyroid function after (131)I treatment for toxic adenoma. Hormones (Athens). 2002 Apr-Jun;1(2):99-103.

• 摘要

57.  Verloop H, Louwerens M, Schoones JW, et al. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012 Jul;97(7):2243-55.

• 全文
• 摘要

58.  American Thyroid Association Taskforce On Radioiodine Safety, Sisson JC, Freitas J, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011 Apr;21(4):335-46.

• 摘要